This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Morimoto, L. M. Articles by Potter, J. D. Search for Related Content PubMed PubMed Citation Articles by Morimoto, L. M. Articles by Potter, J. D.

Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors

¹ Public Health Sciences, Fred Hutchinson Cancer Research Center; ² Department of Epidemiology, University of Washington, Seattle, Washington; and ³ University of Wisconsin, Comprehensive Cancer Center, Madison, Wiscosin

Requests for reprints: Polly Newcomb, 1100 Fairview Avenue North, M4-B402, Seattle, WA 98109. Phone: 206-667-3476; Fax: 206-667-7850. E-mail: pnewcomb{at}fhcrc.org

Insulin-like growth factors (IGFs) play key roles in cell proliferation and apoptosis. Whereas relatively stable within individuals, IGFs vary substantially between individuals, and a large component of this variation may be determined by genetic factors. Several polymorphisms in IGF genes have been identified, although their functional significance is not clear. We evaluated the association of polymorphisms in IGF-1 and IGFBP-3 and circulating levels of IGF-1 and IGFBP-3 in 323 population-based control subjects enrolled in a case-control study of colorectal cancer from September 1999 through February 2002. Total IGF-1 and IGFBP-3 levels were measured using ELISA assays, and all subjects were genotyped for a microsatellite polymorphism in IGF-1 and a single nucleotide polymorphism in IGFBP-3. Multiple linear regression was used to assess the association of genotype with circulating IGFs. IGF-1 levels were unrelated to either polymorphism. IGFBP-3 was significantly associated with IGFBP-3 genotype, with IGFBP-3 levels increasing from CC (1,895 ng/mL) GC (2,029 ng/mL) GG (2,182 ng/mL), (p-trend < 0.001). Having an IGF-1 genotype other than homozygous for the 19-repeat allele was associated with higher IGFBP-3 levels (1,945 versus 2,052 ng/mL). Furthermore, both IGF-1 and IGFBP-3 genotypes modified the relationship between postmenopausal hormone use and IGFs. This analysis provides evidence that common variation in IGF genes may contribute to the variation in circulating levels observed between individuals.

This article has been cited by other articles:

				C. Palles, N. Johnson, B. Coupland, C. Taylor, J. Carvajal, J. Holly, I. S. Fentiman, I. dos Santos Silva, A. Ashworth, J. Peto, et al. Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy Hum. Mol. Genet., May 15, 2008; 17(10): 1457 - 1464. [Abstract] [Full Text] [PDF]

				S. H. Siahpush, T. L. Vaughan, J. N. Lampe, R. Freeman, S. Lewis, R. D. Odze, P. L. Blount, K. Ayub, P. S. Rabinovitch, B. J. Reid, et al. Longitudinal Study of Insulin-like Growth Factor, Insulin-like Growth Factor Binding Protein-3, and their Polymorphisms: Risk of Neoplastic Progression in Barrett's Esophagus Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2387 - 2395. [Abstract] [Full Text] [PDF]

				W. Hernandez, C. Grenade, E. R. Santos, C. Bonilla, C. Ahaghotu, and R. A. Kittles IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans Carcinogenesis, October 1, 2007; 28(10): 2154 - 2159. [Abstract] [Full Text] [PDF]

				C. Chen, R. Freeman, L. F. Voigt, A. Fitzpatrick, S. R. Plymate, and N. S. Weiss Prostate Cancer Risk in Relation to Selected Genetic Polymorphisms in Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-3, and Insulin-like Growth Factor-I Receptor Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2461 - 2466. [Abstract] [Full Text] [PDF]

				W. Cozen, M. Gebregziabher, D. V. Conti, D. J. Van Den Berg, G. A. Coetzee, S. S. Wang, N. Rothman, L. Bernstein, P. Hartge, A. Morhbacher, et al. Interleukin-6-Related Genotypes, Body Mass Index, and Risk of Multiple Myeloma and Plasmacytoma. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2285 - 2291. [Abstract] [Full Text] [PDF]